Update on Retinal Drug Toxicities

PURPOSE OF REVIEW: This review aims to provide an update on the clinical presentations and diagnostic findings of drug-induced retinal toxicities. RECENT FINDINGS: Several newly FDA-approved medications have been associated with acute retinal toxicities, including brolucizumab, MEK inhibitors, ulixe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, S. Tammy, Ponugoti, Arathi, Deaner, Jordan D., Vajzovic, Lejla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Retina (R Goldhardt, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688906/
https://www.ncbi.nlm.nih.gov/pubmed/34956737
http://dx.doi.org/10.1007/s40135-021-00277-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688906/
https://www.ncbi.nlm.nih.gov/pubmed/34956737
http://dx.doi.org/10.1007/s40135-021-00277-x

Ejemplares similares